|
Buprenorphine in the Treatment of Opioid Dependence |
|
| Home > Resources > Bibliography > Patient Assessment and Selection | |
Patient Assessment and SelectionAmerican Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association, 1994. Brooner RK, King VL, Kidorf M, Schmidt CW, and Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry (54):71–80, 1997. O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, and Rounsaville BJA. Pilot study of primary-care-based buprenorphine maintenance for heroin dependence. American Journal of Drug and Alcohol Abuse (22):523–531, 1996. O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, Rounsaville BJ, Pakes JA, and Schottenfeld RSA. Randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. American Journal of Medicine (105):100–105, 1998. Pickens RW and Svikis DS. (eds.) Biological Vulnerability to Drug Abuse. NIDA Research Monograph, Number 89. Rockville, MD: National Institute on Drug Abuse, 1988. Return to the table of contents. |
|
|
|
|
|
||
| Site Map | HHS Privacy Statement | Contact Us | Danya Learning Center | ||
| Developed by the American Academy of Addiction Psychiatry and Danya International with funding from the Center for Substance Abuse Treatment. | ||
| Last updated: September 20, 2002. | ||